Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-β in mammary epithelial cells via a MMP-dependent mechanism

Carcinogenesis

Volumn 29, Issue 12, 2008, Pages 2243-2251

  Lee, Yong Hun ^a   Albig, Allan R ^a,b   Regner, Maryann ^a   Schiemann, Barbara J ^a   Schiemann, William P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b INDIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FIBULIN 5; MATRIX METALLOPROTEINASE; MESSENGER RNA; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL POLARITY; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE REPRESSION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; METALLOPROTEASES; MICE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 57349137178     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn199     Document Type: Article

References (48)

1. Thiery,J.P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer, 2, 442-454.
2. Thiery,J.P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol., 15, 740-746.
3. Grunert,S. et al. (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol., 4, 657-665.
4. Miettinen,P.J. et al. (1994) TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J. Cell Biol., 127, 2021-2036.
5. Zavadil,J. et al. (2005) TGF-β and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764-5774.
6. Galliher,A.J. et al. (2006) Role of TGF-β in cancer progression. Future Oncol., 2, 743-763.
7. Blobe,G.C. et al. (2000) Role of TGF-β in human disease. N. Engl. J. Med., 342, 1350-1358.
8. Wakefield,L.M. et al. (2002) TGF-β signaling: Positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev., 12 22-29.
9. Schiemann,W.P. et al. (2002) Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by TGF-β and affects protein kinase cascades. J. Biol. Chem. 277, 27367-27377.
10. Albig,A.R. et al. (2004) Fibulin-5 antagonizes VEGF signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol., 23 367-379.
11. Albig,A.R. et al. (2006) Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res., 66, 2621-2629.
12. Albig,A.R. et al. (2005) Fibulin-5 function during tumorigenesis. Future Oncol., 1, 23-35.
13. Argraves,W.S. et al. (2003) Fibulins: Physiological and disease perspectives. EMBO Rep., 4, 1127-1131.
14. Chu,M.L. et al. (2004) Fibulins in development and heritable disease. Birth Defects Res. C Embryo Today, 72, 25-36.
15. Lemaire,R. et al. (2004) Fibulin-2 and fibulin-5 alterations in Tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. J. Invest. Dermatol., 123, 1063-1069.
16. Sokol,P. et al. (2005) The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by TGF-β. Breast Cancer Res., 7, R844-R853.
17. Fata,J.E. et al. (2004) Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res., 6, 1-11.
18. Blobe,G.C. et al. (2001) Functional roles for the cytoplasmic domain of the type III TGF-β receptor in regulating TGF-β signaling. J. Biol. Chem., 276, 24627-24637.
19. Nawshad,A. et al. (2005) TGF-β signaling during epithelial-mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells Tissues Organs, 179, 11-23.
20. Fan,J.M. et al. (1999) TGF-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56, 1455-1467.
21. Hales,A.M. et al. (1994) TGF-β1 induces lens cells to accumulate α-smooth muscle actin, a marker for subcapsular cataracts. Curr. Eye Res., 13, 885-890.
22. Kasai,H. et al. (2005) TGF-β1 induces human alveolar epithelial to mesenchymal cell transition. Respir Res., 6, 56.
23. Nakamura,T. et al. (1999) DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J. Biol. Chem., 274, 22476-22483.
24. Kowal,R.C. et al. (1999) EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ. Res., 84, 1166-1176.
25. Lee,M.J. et al. (2004) Fibulin-5 promotes wound healing in vivo. J. Am. Coll. Surg., 199, 403-410.
26. Nakamura,T. et al. (2002) Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature, 415, 171-175.
27. Yanagisawa,H. et al. (2002) Fibulin-5 is an elastin-binding protein essential for elastic fiber development in vivo. Nature, 415, 168-171.
28. Loeys,B. et al. (2002) Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol. Genet., 11, 2113-2118.
29. Markova,D. et al. (2003) Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLNS) gene. Am. J. Hum. Genet., 72, 998-1004.
30. Kapetanopoulos,A. et al. (2002) Direct interaction of the extracellular matrix protein DANCE with apolipoprotein(a) mediated by the kringle IV-type 2 domain. Mol. Genet. Genomics, 267, 440-446.
31. Liu,X. et al. (2004) Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet., 36, 178-182.
32. Hirai,M. et al. (2007) Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol., 176, 1061-1071.
33. Zanetti,M. et al. (2004) EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol. Cell. Biol., 24, 638-650.
34. Hirai,M. et al. (2007) Latent TGF-β-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J., 26, 3283-3295.
35. Nguyen,A.D. et al. (2004) Fibulin-5 is a novel binding protein for extra-cellular superoxide dismutase. Circ. Res., 95, 1067-1074.
36. El-Hallous,E. et al. (2007) Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin. J. Biol. Chem., 282, 8935-8946.
37. Bhowmick,N.A. et al. (2001) Integrin β1 signaling is necessary for TGF-β activation of p38 MAPK and epithelial plasticity. J. Biol. Chem., 276, 46707-46713.
38. Galliher,A.J. et al. (2006) β3 integrin and Src facilitate TGF-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res., 8, R42.
39. Galliher,A.J. et al. (2007) Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res., 67 3752-3758.
40. Galliher-Beckley,A.J. et al. (2008) Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-β. Carcinogenesis, 29, 244-251.
41. Lucero,H.A. et al. (2006) Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell. Mol. Life Sci., 63, 2304-2316.
42. Payne,S.L. et al. (2007) Paradoxical roles for lysyl oxidases in cancer - a prospect. J. Cell. Biochem., 101, 1338-1354.
43. Anderson,A.R. et al. (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell, 127, 905-915.
44. Paszek,M.J. et al. (2004) The tension mounts: Mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia, 9, 325-342.
45. Erler,J.T. et al. (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440, 1222-1226.
46. Kirschmann,D.A. et al. (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res., 62, 4478-4483.
47. Payne,S.L. et al. (2005) Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res., 65, 11429-11436.
48. Payne,S.L. et al. (2006) Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex. J. Cell. Biochem., 98, 827-837.